Patents by Inventor Ilan Cohn

Ilan Cohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180260419
    Abstract: A method for constructing a database, comprises permitting a plurality of users to enter individual-associated data bits (IDBs) into a computerized system, each of the IDBs comprising at least one personal identifier relating to the user and relationship data comprising data on one or more related individuals and the nature of relationship; and processing the entered IDBs to generate an individual-identifier data set (IDS), one for each identified individual, being either one of the users or one of the related individuals and construct a database comprising IDSs of identified individuals.
    Type: Application
    Filed: March 5, 2018
    Publication date: September 13, 2018
    Inventor: ILAN COHN
  • Patent number: 9946736
    Abstract: A method including entering individual-associated data bits (IDBs) into a computerized system, the set of data of each of the IDBs including at least one personal identifier of an individual and relationship data including data on one or more related individuals and the nature of the relationship, processing the entered IDBs on a processor, generating an individual-identifier data set (IDS) for each identified individual or one of the related individuals having data in the processed IDBs, and storing IDSs of identified individuals in a database.
    Type: Grant
    Filed: January 21, 2007
    Date of Patent: April 17, 2018
    Inventors: Dan Rolls, Ilan Cohn
  • Patent number: 8156158
    Abstract: A system and method are presented for managing and using (e.g. for commercial or medical use) of a database. A verified database of a plurality of identified individuals is provided. The verified database comprises a plurality of individual-identifier data sets (IDSs) and relationship data. The verified database is processed in accordance with one or more parameters or conditions selected in accordance with at least one medical application, and a sub-group database is created including data records of the individuals from the verified database having said one or more selected parameters or conditions. This allows collection of data comprising the one or more selected parameters or conditions and delivery of at least part of the collected data to one or more users, and enables applying data from the verified database to provide personalized medicine service to at least one of the identified individuals.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: April 10, 2012
    Assignee: Famillion Ltd.
    Inventors: Dan Rolls, Ilan Cohn, Iphtach Cohen
  • Publication number: 20100287213
    Abstract: A system and method are presented for managing and using (e.g. for commercial or medical use) of a database. A verified database of a plurality of identified individuals is provided. The verified database comprises a plurality of individual-identifier data sets (IDSs) and relationship data. The verified database is processed in accordance with one or more parameters or conditions selected in accordance with at least one medical application, and a sub-group database is created including data records of the individuals from the verified database having said one or more selected parameters or conditions. This allows collection of data comprising the one or more selected parameters or conditions and delivery of at least part of the collected data to one or more users, and enables applying data from the verified database to provide personalized medicine service to at least one of the identified individuals.
    Type: Application
    Filed: July 18, 2007
    Publication date: November 11, 2010
    Inventors: Dan Rolls, Ilan Cohn, Iphtach Cohen
  • Patent number: 7825102
    Abstract: The present invention provides a method for treating dry eye condition in an individual comprising administrating to said individual an amount of A3 adenosine receptor (A3AR) agonist, the amount being effective to ameliorate symptoms of dry eye in the individual. In accordance with one embodiment, the dry eye condition is manifested by one or more ophthalmologic clinical symptoms selected from foreign body sensation, burning, itching, irritation, redness, eye pain, blurred vision, degraded vision and excessive tearing. A preferred A3RAg in accordance with the invention is N6-(3-iodobenzyl)-adenosine-5?-N-methyluronamide (IB-MECA).
    Type: Grant
    Filed: November 28, 2006
    Date of Patent: November 2, 2010
    Assignee: Can-Fite Biopharma Ltd.
    Inventors: Pnina Fishman, Tatiana Reitblat, Ilan Cohn
  • Publication number: 20100222369
    Abstract: The present invention provides a method for treating dry eye condition in an individual comprising administrating to said individual an amount of A3 adenosine receptor (A3AR) agonist, the amount being effective to ameliorate symptoms of dry eye in the individual. In accordance with one embodiment, the dry eye condition is manifested by one or more opthalmologic clinical symptoms selected from foreign body sensation, burning, itching, irritation, redness, eye pain, blurred vision, degraded vision and excessive tearing. A preferred A3RAg in accordance with the invention is N6-(3-iodobenzyl)-adenosine-5?-N-methyluronamide (IB-MECA).
    Type: Application
    Filed: May 6, 2010
    Publication date: September 2, 2010
    Applicant: CAN-FITE BIOPHARMA LTD.
    Inventors: Pnina FISHMAN, Tatiana REITBLAT, Ilan COHN
  • Publication number: 20090248653
    Abstract: A method for constructing a database, comprises permitting a plurality of users to enter individual-associated data bits (IDBs) into a computerized system, each of the IDBs comprising at least one personal identifier relating to the user and relationship data comprising data on one or more related individuals and the nature of relationship; and processing the entered IDBs to generate an individual-identifier data set (IDS), one for each identified individual, being either one of the users or one of the related individuals and construct a database comprising IDSs of identified individuals.
    Type: Application
    Filed: January 21, 2007
    Publication date: October 1, 2009
    Inventors: Dan Rolls, Ilan Cohn
  • Publication number: 20070099865
    Abstract: The present invention provides a method for treating dry eye condition in an individual comprising administrating to said individual an amount of A3 adenosine receptor (A3AR) agonist, the amount being effective to ameliorate symptoms of dry eye in the individual. In accordance with one embodiment, the dry eye condition is manifested by one or more ophthalmologic clinical symptoms selected from foreign body sensation, burning, itching, irritation, redness, eye pain, blurred vision, degraded vision and excessive tearing. A preferred A3RAg in accordance with the invention is N6-(3-iodobenzyl)-adenosine-5?-N-methyluronamide (IB-MECA).
    Type: Application
    Filed: November 28, 2006
    Publication date: May 3, 2007
    Inventors: Pnina Fishman, Tatiana Reitblat, Ilan Cohn
  • Patent number: 6911435
    Abstract: Adenosine and active agent which interact with the adenosine system are used to treat conditions of weakened, immune system, as an anti-cancer therapy and for improving the therapeutic index of a variety of therapeutic drugs.
    Type: Grant
    Filed: July 10, 1998
    Date of Patent: June 28, 2005
    Assignee: Can-Fite Biopharma Ltd.
    Inventors: Ilan Cohn, Pnina Fishman
  • Publication number: 20050101560
    Abstract: A method for treating an individual with IB-MECA to achieve a therapeutic effect is provided. The method comprises administering to the individual a dose of IB-MECA in an amount and for a time such so as to achieve a maximal blood level of less than about 1.60 nM.
    Type: Application
    Filed: November 12, 2003
    Publication date: May 12, 2005
    Applicant: CAN-FITE BIOPHARMA LTD.
    Inventors: Steve Warrington, Michael Silverman, William Kerns, Pnina Fishman, Ilan Cohn
  • Patent number: 6790839
    Abstract: The present invention relates to a method of inducing proliferation of bone marrow cells in a subject, compromising administering to the subject an effective amount of an adenosine A1 receptor agonist. The present invention further relates to a method for preventing reduction in level of leukocytes in a subject as a result of a treatment comprising administering to the individual an effective amount of an adenosine A1 receptor agonist. In addition, the invention relates to a method of treatment of an individual comprising administering to the subject a therapeutic drug in combination with an adenosine A1 receptor agonist.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: September 14, 2004
    Assignee: Can-Fite Biopharma Ltd.
    Inventors: Pnina Fishman, Ilan Cohn
  • Patent number: 6638914
    Abstract: The present invention relates to pharmaceutical compositions for use in inducing proliferation of the hematopoietic system, in particular, of bone marrow cells, comprising a pharmaceutically acceptable carrier, excipient or diluent and, as an active ingredient, an effective amount of an adenosine A1 receptor agonist. The pharmaceutical composition of the present invention may be used to induce proliferation of bone marrow cells, in a variety of clinical situations where such proliferation is therapeutically beneficial. The active ingredient within the pharmaceutical composition of the invention may be a compound of general formula (I) as described herein or any other compound or substance which specifically binds to and/or activates the A1 adenosine receptor and acts as an agonist to the receptor's natural ligand.
    Type: Grant
    Filed: January 9, 2001
    Date of Patent: October 28, 2003
    Assignee: Can-Fite Biopharma Ltd.
    Inventors: Pnina Fishman, Ilan Cohn
  • Publication number: 20020037871
    Abstract: The present invention relates to a method for inducing proliferation of the hematopoietic system, in particular, of bone marrow cells, comprising administering to a subject an effective amount of an adenosine A1 receptor agonist. The method of the invention may be utilized n a variety of clinical situations where such proliferation is therapeutically beneficial.
    Type: Application
    Filed: June 4, 2001
    Publication date: March 28, 2002
    Inventors: Pnina Fishman, Ilan Cohn
  • Publication number: 20010031742
    Abstract: The present invention relates to a method of inducing proliferation of bone marrow cells in a subject, compromising administering to the subject an effective amount of an adenosine A1 receptor agonist. The present invention further relates to a method for preventing reduction in level of leukocytes in a subject as a result of a treatment comprising administering to the individual an effective amount of an adenosine A1 receptor agonist. In addition, the invention relates to a method of treatment of an individual comprising administering to the subject a therapeutic drug in combination with an adenosine A1 receptor agonist.
    Type: Application
    Filed: February 14, 2001
    Publication date: October 18, 2001
    Inventors: Pnina Fishman, Ilan Cohn